BIOMARIN PHARMACEUTICAL INC (BMRN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q4 '09: 324.7M Q1 '10: 335.6M Q2 '10: 344.8M Q3 '10: 361.7M Q4 '10: 376.3M Q1 '11: 400.8M Q2 '11: 419.5M Q3 '11: 435.1M Q4 '11: 441.4M Q1 '12: 448.6M Q2 '12: 461.9M Q3 '12: 476.6M Q4 '12: 500.7M Q1 '13: 512M Q2 '13: 524.8M Q3 '13: 533.5M Q4 '13: 548.5M Q1 '14: 572.1M Q2 '14: 627.1M Q3 '14: 666.8M Q4 '14: 750M Q1 '15: 801.3M Q2 '15: 859.7M Q3 '15: 892M Q4 '15: 889.9M Q1 '16: 923.7M Q2 '16: 973.7M Q3 '16: 1B Q4 '16: 1.1B Q1 '17: 1.2B Q2 '17: 1.2B Q3 '17: 1.3B Q4 '17: 1.3B Q1 '18: 1.4B Q2 '18: 1.4B Q3 '18: 1.5B Q4 '18: 1.5B Q1 '19: 1.5B Q2 '19: 1.5B Q3 '19: 1.6B Q4 '19: 1.7B Q1 '20: 1.8B Q2 '20: 1.8B Q3 '20: 1.9B Q4 '20: 1.9B Q1 '21: 1.8B Q2 '21: 1.9B Q3 '21: 1.8B Q4 '21: 1.8B Q1 '22: 1.9B Q2 '22: 1.9B Q3 '22: 2B Q4 '22: 2.1B Q1 '23: 2.2B Q2 '23: 2.2B Q3 '23: 2.3B Q4 '23: 2.4B Q1 '24: 2.5B Q2 '24: 2.6B Q3 '24: 2.8B Q4 '24: 2.9B Q1 '25: 3B Q2 '25: 3.1B Q3 '25: 3.1B Q4 '25: 3.2B Q1 '26: 3.2B Q2 '26: 3.4B Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit TTM

0 900M 1.8B 2.7B Q4 '09: 258.7M Q1 '10: 266.7M Q2 '10: 281.3M Q3 '10: 295.2M Q4 '10: 306M Q1 '11: 327.1M Q2 '11: 340.9M Q3 '11: 352.2M Q4 '11: 357.3M Q1 '12: 368.2M Q2 '12: 377.3M Q3 '12: 389.8M Q4 '12: 408.9M Q1 '13: 416.8M Q2 '13: 430.6M Q3 '13: 435.9M Q4 '13: 460.1M Q1 '14: 481.4M Q2 '14: 527.7M Q3 '14: 565.5M Q4 '14: 627.7M Q1 '15: 670.9M Q2 '15: 722.4M Q3 '15: 749.7M Q4 '15: 737.9M Q1 '16: 759.6M Q2 '16: 796M Q3 '16: 851.2M Q4 '16: 907.2M Q1 '17: 967.4M Q2 '17: 980M Q3 '17: 1B Q4 '17: 1.1B Q1 '18: 1.1B Q2 '18: 1.1B Q3 '18: 1.2B Q4 '18: 1.2B Q1 '19: 1.2B Q2 '19: 1.2B Q3 '19: 1.3B Q4 '19: 1.3B Q1 '20: 1.4B Q2 '20: 1.4B Q3 '20: 1.4B Q4 '20: 1.3B Q1 '21: 1.3B Q2 '21: 1.4B Q3 '21: 1.4B Q4 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.5B Q4 '22: 1.6B Q1 '23: 1.7B Q2 '23: 1.7B Q3 '23: 1.8B Q4 '23: 1.9B Q1 '24: 1.9B Q2 '24: 2.1B Q3 '24: 2.2B Q4 '24: 2.3B Q1 '25: 2.3B Q2 '25: 2.4B Q3 '25: 2.5B Q4 '25: 2.5B Q1 '26: 2.5B Q2 '26: 2.6B Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-900M -600M -300M 0 300M 600M 900M Q1 '10: 23.6M Q2 '10: 22.3M Q3 '10: 10.3M Q4 '10: 544K Q1 '11: 48K Q2 '11: -2.2M Q3 '11: -15.8M Q4 '11: -33.9M Q1 '12: -58M Q2 '12: -89.8M Q3 '12: -84.7M Q4 '12: -110.2M Q1 '13: -121.3M Q2 '13: -110.4M Q3 '13: -150.6M Q4 '13: -156M Q1 '14: -149.5M Q2 '14: -148.4M Q3 '14: -86.4M Q4 '14: -92.9M Q1 '15: -132.3M Q2 '15: -177.7M Q3 '15: -270.8M Q4 '15: -110.7M Q1 '16: -125.8M Q2 '16: -634.3M Q3 '16: -612.5M Q4 '16: -803.4M Q1 '17: -742.7M Q2 '17: -208.7M Q3 '17: -162.4M Q4 '17: -14.7M Q1 '18: -38.9M Q2 '18: -25.3M Q3 '18: -27.3M Q4 '18: -123.5M Q1 '19: -133.1M Q2 '19: -149.2M Q3 '19: -129.4M Q4 '19: -100.5M Q1 '20: 58.5M Q2 '20: 58.9M Q3 '20: -1.1M Q4 '20: -43.4M Q1 '21: -123.3M Q2 '21: -70.7M Q3 '21: -68M Q4 '21: -82.3M Q1 '22: 29.9M Q2 '22: 57.4M Q3 '22: 108.2M Q4 '22: 161M Q1 '23: 86.1M Q2 '23: 112.5M Q3 '23: 145.4M Q4 '23: 185.8M Q1 '24: 211.8M Q2 '24: 266.7M Q3 '24: 350.1M Q4 '24: 484.2M Q1 '25: 619.6M Q2 '25: 776.1M Q3 '25: 615.5M Q4 '25: 409.5M Q1 '26: 315.2M Q2 '26: 149.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income TTM

-900M -600M -300M 0 300M 600M 900M Q4 '11: -53.8M Q1 '12: -73.4M Q2 '12: -100.4M Q3 '12: -88.1M Q4 '12: -114.3M Q1 '13: -130.2M Q2 '13: -119.7M Q3 '13: -167.4M Q4 '13: -176.4M Q1 '14: -174.7M Q2 '14: -186.6M Q3 '14: -126.2M Q4 '14: -134M Q1 '15: -163.4M Q2 '15: -211.8M Q3 '15: -310.2M Q4 '15: -171.8M Q1 '16: -187.3M Q2 '16: -524.4M Q3 '16: -470.9M Q4 '16: -630.2M Q1 '17: -563.4M Q2 '17: -181.3M Q3 '17: -156.4M Q4 '17: -117M Q1 '18: -144.9M Q2 '18: -124.9M Q3 '18: -125M Q4 '18: -77.2M Q1 '19: -89.5M Q2 '19: -110.2M Q3 '19: -42.5M Q4 '19: -23.8M Q1 '20: 114M Q2 '20: 122.3M Q3 '20: 852M Q4 '20: 854M Q1 '21: 790M Q2 '21: 832.1M Q3 '21: 10.8M Q4 '21: -64.1M Q1 '22: 39.3M Q2 '22: 54.1M Q3 '22: 83.9M Q4 '22: 141.6M Q1 '23: 71.6M Q2 '23: 100M Q3 '23: 147M Q4 '23: 167.6M Q1 '24: 205.5M Q2 '24: 256.6M Q3 '24: 322.3M Q4 '24: 426.9M Q1 '25: 523.9M Q2 '25: 657.2M Q3 '25: 520.4M Q4 '25: 348.9M Q1 '26: 268.7M Q2 '26: 73M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 300M 600M 900M Q4 '09: 65.9M Q1 '10: 69M Q2 '10: 63.5M Q3 '10: 66.5M Q4 '10: 70.3M Q1 '11: 73.7M Q2 '11: 78.5M Q3 '11: 83M Q4 '11: 84M Q1 '12: 80.3M Q2 '12: 84.6M Q3 '12: 86.8M Q4 '12: 91.8M Q1 '13: 95.2M Q2 '13: 94.2M Q3 '13: 97.7M Q4 '13: 88.4M Q1 '14: 90.7M Q2 '14: 99.3M Q3 '14: 101.2M Q4 '14: 122.3M Q1 '15: 130.4M Q2 '15: 137.3M Q3 '15: 142.3M Q4 '15: 152M Q1 '16: 164.1M Q2 '16: 177.7M Q3 '16: 193.5M Q4 '16: 209.6M Q1 '17: 216.5M Q2 '17: 221.2M Q3 '17: 229.9M Q4 '17: 241.8M Q1 '18: 274.1M Q2 '18: 296.8M Q3 '18: 316.2M Q4 '18: 315.3M Q1 '19: 322.1M Q2 '19: 320.5M Q3 '19: 338.6M Q4 '19: 359.5M Q1 '20: 381.7M Q2 '20: 402.2M Q3 '20: 494M Q4 '20: 524.3M Q1 '21: 533.1M Q2 '21: 562.2M Q3 '21: 476.9M Q4 '21: 470.5M Q1 '22: 467.3M Q2 '22: 463.4M Q3 '22: 476.1M Q4 '22: 503M Q1 '23: 521.5M Q2 '23: 529M Q3 '23: 540.8M Q4 '23: 532.1M Q1 '24: 521.8M Q2 '24: 521.6M Q3 '24: 582M Q4 '24: 580.2M Q1 '25: 606.6M Q2 '25: 626.2M Q3 '25: 577.9M Q4 '25: 717.4M Q1 '26: 760.9M Q2 '26: 813.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Cash Flow TTM

-350M 0 350M 700M 1.1B Q2 '10: 73.4M Q3 '10: 54M Q4 '11: 18.4M Q1 '12: 14.7M Q2 '12: -243K Q3 '12: 5.1M Q4 '12: 17.6M Q1 '13: -7.2M Q2 '13: -12.6M Q3 '13: -36.4M Q4 '13: -59.6M Q1 '14: -54.5M Q2 '14: -59.1M Q3 '14: -58.2M Q4 '14: -70.8M Q1 '15: -181.7M Q2 '15: -183.3M Q3 '15: -177.6M Q4 '15: -219.5M Q1 '16: -253.1M Q2 '16: -286M Q3 '16: -293.5M Q4 '16: -227.8M Q1 '17: -136.8M Q2 '17: -72.2M Q3 '17: -23.6M Q4 '17: -8.8M Q1 '18: 29.2M Q2 '18: -23.5M Q3 '18: -14.6M Q4 '18: 20.2M Q1 '19: 7.8M Q2 '19: 17.4M Q3 '19: 40.3M Q4 '19: 48.3M Q1 '20: 87.9M Q2 '20: 140M Q3 '20: 156.1M Q4 '20: 85.4M Q1 '21: 214.1M Q2 '21: 269.1M Q3 '21: 280M Q4 '21: 304.5M Q1 '22: 145.6M Q2 '22: 119M Q3 '22: 180.3M Q4 '22: 175.9M Q1 '23: 147.4M Q2 '23: 161.2M Q3 '23: 138.6M Q4 '23: 159.3M Q1 '24: 280.2M Q2 '24: 328.9M Q3 '24: 414.7M Q4 '24: 572.8M Q1 '25: 700.3M Q2 '25: 766.8M Q3 '25: 914M Q4 '25: 828M Q1 '26: 874.3M Q2 '26: 857.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-600M -300M 0 300M 600M 900M Q2 '10: -5.2M Q3 '10: -7.3M Q4 '11: -54.8M Q1 '12: -58.4M Q2 '12: -81M Q3 '12: -34.2M Q4 '12: -27M Q1 '13: -57.5M Q2 '13: -63.8M Q3 '13: -85.7M Q4 '13: -124.8M Q1 '14: -131.5M Q2 '14: -145.7M Q3 '14: -156.7M Q4 '14: -167.3M Q1 '15: -298.5M Q2 '15: -315.5M Q3 '15: -329.2M Q4 '15: -447.2M Q1 '16: -482.2M Q2 '16: -505M Q3 '16: -494.1M Q4 '16: -376.2M Q1 '17: -309.1M Q2 '17: -266.8M Q3 '17: -234.5M Q4 '17: -208M Q1 '18: -131.1M Q2 '18: -158.5M Q3 '18: -157M Q4 '18: -124.4M Q1 '19: -135.4M Q2 '19: -136M Q3 '19: -96M Q4 '19: -96.8M Q1 '20: -68.9M Q2 '20: -10.3M Q3 '20: 22M Q4 '20: -28.9M Q1 '21: 114.8M Q2 '21: 173.4M Q3 '21: 182.1M Q4 '21: 209M Q1 '22: 46.7M Q2 '22: 15.6M Q3 '22: 66.3M Q4 '22: 54.9M Q1 '23: 30.8M Q2 '23: 50.2M Q3 '23: 35.1M Q4 '23: 62.6M Q1 '24: 181.8M Q2 '24: 230.8M Q3 '24: 319.9M Q4 '24: 487.4M Q1 '25: 624.2M Q2 '25: 694.9M Q3 '25: 832.1M Q4 '25: 725M Q1 '26: 767.1M Q2 '26: 738.2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '09: 101.2M Q3 '09: 101.8M Q1 '10: 103.7M Q2 '10: 101.8M Q3 '10: 131.3M Q1 '11: 110.7M Q2 '11: 111.1M Q3 '11: 112.3M Q1 '12: 115.1M Q2 '12: 117.9M Q1 '13: 128M Q2 '13: 139.6M Q3 '13: 140.8M Q1 '14: 144.2M Q2 '14: 146.4M Q3 '14: 159.3M Q1 '15: 157.6M Q2 '15: 160.4M Q3 '15: 161.1M Q3 '16: 167.7M Q1 '17: 172.7M Q3 '17: 175.1M Q1 '18: 176.2M Q2 '18: 176.9M Q3 '18: 177.5M Q1 '19: 178.3M Q2 '19: 179M Q3 '19: 185.9M Q1 '20: 187.2M Q2 '20: 180.7M Q3 '20: 197.7M Q1 '21: 184.4M Q2 '21: 185.4M Q3 '21: 183.2M Q1 '22: 194.9M Q2 '22: 187.4M Q3 '22: 185.6M Q1 '23: 194.4M Q2 '23: 195M Q3 '23: 191.2M Q1 '24: 199.3M Q2 '24: 200.5M Q3 '24: 197.1M Q1 '25: 196.5M Q2 '25: 197.1M Q3 '25: 192M Q1 '26: 197.7M Q2 '26: 194.5M Q1 '11 Q2 '13 Q2 '15 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q1 '11: 1.62 Q2 '11: 1.58 Q3 '11: -0.26 Q4 '11: -0.49 Q1 '12: -0.66 Q2 '12: -0.88 Q3 '12: -0.76 Q4 '12: -0.95 Q1 '13: -1.05 Q2 '13: -0.94 Q3 '13: -1.28 Q4 '13: -1.29 Q1 '14: -1.25 Q2 '14: -1.32 Q3 '14: -0.89 Q4 '14: -0.93 Q1 '15: -1.09 Q2 '15: -1.37 Q3 '15: -2.02 Q4 '15: -1.07 Q1 '16: -1.15 Q2 '16: -3.22 Q3 '16: -2.84 Q4 '16: -3.82 Q1 '17: -3.40 Q2 '17: -1.03 Q3 '17: -0.88 Q4 '17: -0.66 Q1 '18: -0.83 Q2 '18: -0.71 Q3 '18: -0.71 Q4 '18: -0.44 Q1 '19: -0.50 Q2 '19: -0.62 Q3 '19: -0.25 Q4 '19: -0.13 Q1 '20: 0.63 Q2 '20: 0.68 Q3 '20: 4.39 Q4 '20: 4.40 Q1 '21: 4.05 Q2 '21: 4.28 Q3 '21: 0.07 Q4 '21: -0.36 Q1 '22: 0.18 Q2 '22: 0.26 Q3 '22: 0.42 Q4 '22: 0.73 Q1 '23: 0.37 Q2 '23: 0.51 Q3 '23: 0.76 Q4 '23: 0.87 Q1 '24: 1.06 Q2 '24: 1.32 Q3 '24: 1.66 Q4 '24: 2.21 Q1 '25: 2.70 Q2 '25: 3.38 Q3 '25: 2.67 Q4 '25: 1.80 Q1 '26: 1.39 Q2 '26: 0.39 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.